Chematek exhibited at CPHI India 2025 in Mumbai, at Stand 7.M08 in Hall 7. India is a world-leading centre for pharmaceutical manufacturing and a market where Chematek has held commercial relationships for many years; demand there for safer, more efficient reduction chemistry is growing quickly.
The stand's focus was Synhydrid® and Piperhydride®. Synhydrid® offers controlled hydride delivery under milder conditions than LAH or DIBAL-H, cutting cryogenic requirements, handling risk and work-up complexity. Piperhydride® gives high selectivity for specific reduction targets, an advantage that matters in demanding API synthesis. Conversations over the three days of the show confirmed that Indian manufacturers are actively evaluating both.
The real value of an event like CPHI India is density: formulators, procurement specialists, API manufacturers and research chemists, all in one place for a few days. What they told Chematek's team about their specific challenges feeds directly into how the company develops its products, its technical support and its approach to partnership in the Indian market, backed by the company's Mumbai office and warehouses on both coasts.
Chematek will be back at CPHI India in 2026 to continue building on those conversations.
